+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Blood Glucose Monitoring (BGM) Devices - A Global Market Overview - Product Thumbnail Image

Blood Glucose Monitoring (BGM) Devices - A Global Market Overview

  • Report
  • February 2020
  • 452 Pages
  • Global
From
Global Insulin Pen Market - Product Thumbnail Image

Global Insulin Pen Market

  • Report
  • February 2024
  • 78 Pages
  • Global
From
From
Blood Glucose Monitoring Market in APAC 2022-2026 - Product Thumbnail Image

Blood Glucose Monitoring Market in APAC 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Asia Pacific
From
Insulin Pens - Global Strategic Business Report - Product Thumbnail Image

Insulin Pens - Global Strategic Business Report

  • Report
  • May 2024
  • 92 Pages
  • Global
From
From
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Insulin Pens Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Insulin Pens Market - Global Outlook & Forecast 2022-2027

  • Report
  • March 2022
  • 260 Pages
  • Global
From
Loading Indicator